Celldex Therapeutics, Inc.
US ˙ NasdaqCM ˙ US15117B2025

SecurityCLDX / Celldex Therapeutics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership240,594 shares
Latest Disclosed Value $ 6,534,533
Barclays Plc ownership in CLDX / Celldex Therapeutics, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 240,594 shares of Celldex Therapeutics, Inc. (US:CLDX) valued at $6,534,533 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 244,825 shares of Celldex Therapeutics, Inc.. This represents a change in shares of -1.73% during the quarter. The current value of the position is $7,162,483 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (CLDX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CLDX / Celldex Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 240,594 -4,231 -1.73 6,535 3.17 0.0016
2026-03-31 2025-09-30 13F/A-3 CELLDEX THERAPEUTICS INC COM 15117B202 244,825 -17,900 -6.81 6,334 18.46 0.0014
2026-03-19 2025-09-30 13F/A-2 CELLDEX THERAPEUTICS INC COM 15117B202 130,381 -132,344 4,432 0.0012
2025-11-12 2025-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 244,825 -17,900 6,334 0.0014
2026-02-27 2025-06-30 13F/A-2 CELLDEX THERAPEUTICS INC COM 15117B202 262,725 146,159 125.39 5,346 152.77 0.0012
2025-08-14 2025-06-30 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 262,725 146,159 5 0.0012
2025-08-13 2025-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 262,725 146,159 5 0.0004
2026-03-17 2025-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 116,566 -26,348 -18.44 2,116 -41.43 0.0006
2025-05-15 2025-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 116,566 -26,348 2 0.0006
2026-03-19 2024-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 142,914 12,533 9.61 3,611 -18.51 0.0010
2025-02-13 2024-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 142,914 12,533 4 0.0010
2026-03-31 2024-09-30 13F/A-2 CELLDEX THERAPEUTICS INC COM 15117B202 130,381 76,207 140.67 4,432 121.11 0.0012
2024-11-19 2024-09-30 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 130,381 76,207 4 0.0012
2024-11-15 2024-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 130,381 76,207 4 0.0004
2026-03-23 2024-06-30 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 54,174 -12,540 -18.80 2,005 -28.40 0.0006
2024-08-14 2024-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 54,174 -12,540 2 0.0006
2026-03-24 2024-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 66,714 -79,180 -54.27 2,800 -51.62 0.0010
2024-05-15 2024-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 66,714 -79,180 3 0.0010
2026-03-25 2023-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 145,894 2,431 1.69 5,786 46.56 0.0021
2024-02-15 2023-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 145,894 2,431 6 0.0021
2026-03-26 2023-09-30 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 143,463 -28,671 -16.66 3,948 -32.40 0.0025
2023-11-07 2023-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 143,463 -28,671 4 0.0025
2026-03-30 2023-06-30 13F/A-2 CELLDEX THERAPEUTICS INC COM 15117B202 172,134 63,110 57.89 5,841 48.90 0.0037
2023-09-20 2023-06-30 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 172,134 63,110 6 0.0037
2023-08-03 2023-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 172,134 63,110 6 0.0037
2026-03-30 2023-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 109,024 -7,447 -6.39 3,923 -24.45 0.0018
2023-05-04 2023-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 109,024 -7,447 4 0.0018
2026-03-30 2022-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 116,471 -28,116 -19.45 5,191 27.73 0.0023
2023-02-13 2022-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 116,471 -28,116 5 0.0023
2022-11-03 2022-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 144,587 47,500 48.93 4,064 55.23 0.0044
2022-08-12 2022-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 97,087 -109,613 -53.03 2,618 -62.82 0.0016
2022-05-16 2022-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 206,700 66,748 47.69 7,041 30.20 0.0055
2022-02-23 2021-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 139,952 100,184 251.92 5,408 151.89 0.0020
2022-02-14 2021-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 139,952 100,184 5,408 0.0006
2021-11-09 2021-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 39,768 17,943 82.21 2,147 194.11 0.0010
2021-08-13 2021-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 21,825 -33,474 -60.53 730 -35.96 0.0003
2021-05-13 2021-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 55,299 54,799 10,959.80 1,140 12,566.67 0.0006
2021-02-11 2020-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 500 -366 -42.26 9 -30.77 0.0000
2020-11-12 2020-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 866 864 43,200.00 13 0.0000
2020-08-12 2020-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 2 2 0 0.0000
2020-02-10 2019-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 0 -26 -100.00 0 0.0000
2019-11-15 2019-09-30 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B202 26 -3,900 -99.34 0 -100.00
2019-11-14 2019-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 26 -3,900 0 0.0000
2019-08-14 2019-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 3,926 -5,200 -56.98 10 -77.78 0.0000
2019-05-15 2019-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 9,126 9,048 11,600.00 45 0.0000
2019-02-14 2018-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 78 -6,938 -98.89 0 -100.00
2018-11-14 2018-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 7,016 -169,739 -96.03 3 -96.63 0.0000
2018-08-14 2018-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 176,755 134,901 322.31 89 -8.25 0.0001
2018-05-15 2018-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 41,854 20,989 100.59 97 64.41 0.0001
2018-02-14 2017-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 20,865 16,229 350.06 59 353.85 0.0000
2017-11-14 2017-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 4,636 3,577 337.77 13 550.00 0.0000
2017-08-14 2017-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,059 -17,582 -94.32 2 -97.06 0.0000
2017-05-15 2017-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 18,641 9,471 103.28 68 112.50 0.0001
2017-02-14 2016-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 9,170 786 9.38 32 -3.03 0.0000
2016-11-14 2016-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 8,384 8,384 0.00 33 0.0000
2016-08-12 2016-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -33,050 -100.00 0 -100.00
2016-05-16 2016-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 33,050 -168,664 -83.62 99 -96.73 0.0002
2016-02-12 2015-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 201,714 173,879 624.68 3,026 984.59 0.0037
2015-11-13 2015-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 27,835 22,881 461.87 279 125.00 0.0003
2015-08-14 2015-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 4,954 2,161 77.37 124 65.33 0.0001
2015-05-19 2015-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 2,793 -40,695 -93.58 75 -90.42 0.0001
2015-05-14 2015-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 2,793 75
2015-02-13 2014-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 43,488 -9,998 -18.69 783 21.96 0.0008
2014-11-14 2014-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 53,486 5,408 11.25 642 -16.51 0.0006
2014-08-14 2014-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 48,078 -17,563 -26.76 769 -31.09 0.0008
2014-05-15 2014-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 65,641 -66,546 -50.34 1,116 -64.84 0.0013
2014-02-13 2013-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 132,187 62,124 88.67 3,174 29.45 0.0033
2013-11-14 2013-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 70,063 58,250 493.10 2,452 1,232.61 0.0029
2013-08-14 2013-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 11,813 11,813 184 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-08-14 2018-06-30 13F CELLDEX THERAPEUTICS INC OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F CELLDEX THERAPEUTICS INC OPT Call 88,000 205 n/a n/a n/a
2015-08-14 2015-06-30 13F CELLDEX THERAPEUTICS INC OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-19 2015-03-31 13F/A CELLDEX THERAPEUTICS INC OPT Call 25,700 -66.71 694 -50.07 n/a n/a n/a
2015-05-14 2015-03-31 13F CELLDEX THERAPEUTICS INC OPT Call 25,700 694 n/a n/a n/a
2015-02-13 2014-12-31 13F CELLDEX THERAPEUTICS INC OPT Call 77,200 -38.24 1,390 -53.67 n/a n/a n/a
2014-02-13 2013-12-31 13F CELLDEX THERAPEUTICS INC OPT Call 125,000 106.27 3,000 41.44 n/a n/a n/a
2013-11-14 2013-09-30 13F CELLDEX THERAPEUTICS INC OPT Call 60,600 2,121 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-05-14 2015-03-31 13F CELLDEX THERAPEUTICS INC OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-13 2014-12-31 13F CELLDEX THERAPEUTICS INC OPT Put 80,000 0.00 1,440 50.00 n/a n/a n/a
2014-11-14 2014-09-30 13F CELLDEX THERAPEUTICS INC OPT Put 80,000 0.00 960 -25.00 n/a n/a n/a
2014-08-14 2014-06-30 13F CELLDEX THERAPEUTICS INC OPT Put 80,000 0.00 1,280 -5.88 n/a n/a n/a
2014-05-15 2014-03-31 13F CELLDEX THERAPEUTICS INC OPT Put 80,000 654.72 1,360 266.58 n/a n/a n/a
2014-02-13 2013-12-31 13F CELLDEX THERAPEUTICS INC OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2013-11-14 2013-09-30 13F CELLDEX THERAPEUTICS INC OPT Put 10,600 371 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.